User Experience of the OSR M-1

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT04733677
Collaborator
(none)
200
1
20.4
9.8

Study Details

Study Description

Brief Summary

The purpose of this observational study is to verify the user acceptance of the Open Standard Respirator-Model 1 (OSR-M1) by clinicians through pre-trial survey and quantitative fit-testing and post-trial feedback surveys. This study will help to guide further design modifications and clarify quantities of employee populations that may benefit from elastomeric respirator use for the deployment of OSR M1 Air Purifying Respirators (APRs) in the Wake Health network.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study team hypothesizes that the OSR M-1 APR with National Institute for Occupational Safety and Health classification 99% Airborne Particle Filtration (N99) will have increased fit and seal as well as user comfort and acceptance over disposable National Institute for Occupational Safety and Health classification 95% Airborne Particle Filtration (N95) filter facepiece respirators (FFR). The study team is proposing to assess the acceptance and functional usability of the OSR-M1 in Wake Forest Baptist Health System as a N95 disposable FFR alternative for improved protection and economy.

    1. Assess the effectiveness and causation of successful/unsuccessful fit testing of the OSR M1 APR by measuring anthropometry of facial features and performing quantitative fit testing of clinicians.

    2. Determine usability, initial and long-term acceptance of the OSR M1 APR relative to standard issue disposable FFRs through user survey and assessment.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    User Experience of the OSR M1 Reusable Elastomeric Air Purifying Respirator in Non-Clinical Settings
    Actual Study Start Date :
    Mar 19, 2021
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    OSR M-1 N95

    All subjects will be fitted with an OSR M1 N95 mask

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of Successful Fits [Day 1]

      Percentage of subjects that pass fit-factor testing [0%-100%]

    2. Quality of Fit Score [Day 1]

      Scores can range from 0 to 10000 with a higher score denoting a better fit. A score of 100 qualifies as a successful OSHA half-mask respirator fit test.

    3. Percentage of Participants that Fit in a Small Size Mask [Day 1]

      percentage [0%-100%]

    4. Percentage of Participants that fit in a Medium Size Mask [Day 1]

      percentage [0%-100%]

    5. Percentage of Participants that fit in a Large Size Mask [Day 1]

      percentage [0%-100%]

    6. User Acceptance Percentage [Day 10]

      Percentage of participants that prefer the experimental device over currently used device [0-100%]

    Secondary Outcome Measures

    1. Percentage of Impression Change [Baseline through Day 10]

      Changes in impression of the device (pre-trial vs. post-trial) - percentage of positive or negative change [-100% - +100%]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Clinical staff who are issued and routinely wear N95 FFR or equivalent APR's are eligible.
    Exclusion Criteria:
    • Participants unable to pass the fit testing will be excluded from the study.

    • Anyone with a contraindication to wearing an N95 FFR (I.e. pregnancy, underlying medical conditions) will be excluded from the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wake Forest Baptist Health Winston-Salem North Carolina United States 27157

    Sponsors and Collaborators

    • Wake Forest University Health Sciences

    Investigators

    • Principal Investigator: Philip J Brown, PhD, Wake Forest University Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wake Forest University Health Sciences
    ClinicalTrials.gov Identifier:
    NCT04733677
    Other Study ID Numbers:
    • IRB00070715
    First Posted:
    Feb 2, 2021
    Last Update Posted:
    Jun 3, 2022
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Wake Forest University Health Sciences

    Study Results

    No Results Posted as of Jun 3, 2022